📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. (2017)

First Author: Cureton N

Attributed to: Use of nanoparticles to deliver growth signals to the placenta funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/thno.19678

PubMed Identifier: 29109771

Publication URI: http://europepmc.org/abstract/MED/29109771

Type: Journal Article/Review

Volume: 7

Parent Publication: Theranostics

Issue: 15

ISSN: 1838-7640